Singapore markets closed

Cytokinetics, Incorporated (CYTK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
61.32-1.21 (-1.94%)
At close: 04:00PM EDT
61.32 0.00 (0.00%)
After hours: 05:35PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
7,530
7,530
94,588
70,428
55,828
Cost of revenue
330,123
330,123
240,813
159,938
96,951
Gross profit
-322,593
-322,593
-146,225
-89,510
-41,123
Operating expenses
Research development
-
-
-
159,938
96,951
Selling general and administrative
173,612
173,612
177,977
96,803
52,820
Total operating expenses
173,612
173,612
177,977
96,803
52,820
Operating income or loss
-496,205
-496,205
-324,202
-186,313
-93,943
Interest expense
57,668
57,668
51,156
29,332
38,676
Total other income/expenses net
-
-
-24,939
-
-
Income before tax
-526,244
-526,244
-388,955
-215,314
-127,290
Income tax expense
0
-
-
-
-
Income from continuing operations
-526,244
-526,244
-388,955
-215,314
-127,290
Net income
-526,244
-526,244
-388,955
-215,314
-127,290
Net income available to common shareholders
-526,244
-526,244
-388,955
-215,314
-127,290
Basic EPS
-2.80
-5.45
-4.33
-2.80
-1.97
Diluted EPS
-2.80
-5.45
-4.33
-2.80
-1.97
Basic average shares
76,886
96,524
89,825
76,886
64,524
Diluted average shares
76,886
96,524
89,825
76,886
64,524